160 related articles for article (PubMed ID: 21315423)
41. Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma.
Razzaghi R; Agarwal S; Kotlov N; Plotnikova O; Nomie K; Huang DW; Wright GW; Smith GA; Li M; Takata K; Yamadi M; Yao C; O'Shea JJ; Phelan JD; Pittaluga S; Scott DW; Muppidi JR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33237303
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies.
Menke DM; Tiemann M; Camoriano JK; Chang SF; Madan A; Chow M; Habermann TM; Parwaresch R
Am J Clin Pathol; 1996 Mar; 105(3):268-76. PubMed ID: 8602606
[TBL] [Abstract][Full Text] [Related]
43. [Protein expressions of Fas and FasL in B-cell lymphoma and their significances].
Jin Y; Li YC; Su ZL; Tang LY; Feng ZY; Guo SZ
Ai Zheng; 2005 Mar; 24(3):332-6. PubMed ID: 15757536
[TBL] [Abstract][Full Text] [Related]
44. Fas ligand expression in nodal non-Hodgkin's lymphoma.
Müllauer L; Mosberger I; Chott A
Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
[TBL] [Abstract][Full Text] [Related]
45. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.
Greeve J; Philipsen A; Krause K; Klapper W; Heidorn K; Castle BE; Janda J; Marcu KB; Parwaresch R
Blood; 2003 May; 101(9):3574-80. PubMed ID: 12511417
[TBL] [Abstract][Full Text] [Related]
46. [Expression and correlation of Skp2 and p27(kip1) in 92 cases of non-Hodgkin's lymphoma].
Lu JX; Zhang DM; Shen AG; Wang YC; He S; Shao XY; Liu HO; Cheng C
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):373-7. PubMed ID: 17892135
[TBL] [Abstract][Full Text] [Related]
47. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
48. Expression of classical protein kinase C subspecies in non-neoplastic lymphocytes and non-Hodgkin's lymphomas: an immunohistochemical study.
Hojo H; Morimura Y; Abe M; Wakasa H
Pathol Int; 1996 Feb; 46(2):148-54. PubMed ID: 10846563
[TBL] [Abstract][Full Text] [Related]
49. Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
Marín-Rubio JL; de Arriba MC; Cobos-Fernández MA; González-Sánchez L; Ors I; Sastre I; Fernández-Piqueras J; Villa-Morales M
Oncotarget; 2016 Sep; 7(38):61485-61499. PubMed ID: 27556297
[TBL] [Abstract][Full Text] [Related]
50. A marginal zone pattern may be found in different varieties of non-Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B-cell lymphomas simulating splenic marginal zone lymphoma.
Piris MA; Mollejo M; Campo E; Menárguez J; Flores T; Isaacson PG
Histopathology; 1998 Sep; 33(3):230-9. PubMed ID: 9777389
[TBL] [Abstract][Full Text] [Related]
51. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas.
Hoyer KK; Pang M; Gui D; Shintaku IP; Kuwabara I; Liu FT; Said JW; Baum LG; Teitell MA
Am J Pathol; 2004 Mar; 164(3):893-902. PubMed ID: 14982843
[TBL] [Abstract][Full Text] [Related]
52. Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.
Okazaki SI; Yamakawa M; Maeda K; Ohta N; Aoyagi M
J Clin Pathol; 2006 Apr; 59(4):410-6. PubMed ID: 16461807
[TBL] [Abstract][Full Text] [Related]
53. The expression of Bcl-2 by proliferating cells varies in different categories of B-cell lymphoma.
Masir N; Jones M; Lee AM; Goff LK; Clear AJ; Lister A; Marafioti T; Mason DY
Histopathology; 2010 Apr; 56(5):617-26. PubMed ID: 20459572
[TBL] [Abstract][Full Text] [Related]
54. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
[TBL] [Abstract][Full Text] [Related]
55. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
56. Expression of heat-shock protein-90 in non-Hodgkin's lymphomas.
Valbuena JR; Rassidakis GZ; Lin P; Atwell C; Georgakis GV; Younes A; Jones D; Medeiros LJ
Mod Pathol; 2005 Oct; 18(10):1343-9. PubMed ID: 16056252
[TBL] [Abstract][Full Text] [Related]
57. Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas.
Paterson MA; Hosking PS; Coughlin PB
Am J Clin Pathol; 2008 Jul; 130(1):117-26. PubMed ID: 18550480
[TBL] [Abstract][Full Text] [Related]
58. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
59. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
60. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]